Calif. board puts off e-pedigree rule to 2011
The California Board of Pharmacy has announced that it will delay implementation of its electronic pedigree requirements until 2011.
FDA issues draft guidance for the development of drug-eluting stents
FDA issues draft guidelines for drug-eluting stents
FDA seeks comment on pedigree technologies
In a Federal Register notice, the Food & Drug Administration is seeking comments regarding prescription drug authentication
MTM looks to gain traction beyond Medicare program
ClearScript looks to expand its medication therapy management program to employer health plans.
Inflammatory mass leads Medtronic to recall implantable pumps
Medtronic recalls SynchroMed EL, SynchroMed II, and IsoMed implantable pumps
Braun API supplier issues heparin bag recall
Scientific Protein Laboratories issues recall of heparin sodium active pharmaceutical ingredient
Rite Aid rolls out Identigene's OTC DNA paternity test kit
Rite Aid stores market Identigene's retail over-the-counter DNA paternity test kit
PhRMA joins SMARxT drug disposal cause
Another group, the Pharmaceutical Research & Manufacturers of America, is going green
Supplier to physician dispensing doubles capacity at new larger facility
Bryant Ranch Prepack prescription prepacker for physicians opens larger facility
Compassionate use of mifamurtide available for osteosarcoma
Mifamurtide available through compassionate access study
Onsite health centers not being fully tapped by companies
Companies not fully tapping potential of onsite health centers
NCPIE survey finds that most adults use OTCs for themselves and their children
Study shows most adults use non-prescription medications for themselves and their children
More groups demand pathway for biogenerics
New study unveiled at GPhA meeting reveals costs of savings from biogeneric drugs
California hospital fined for heparin overdose
Cedars-Sinai Medical Center must pay a fine of $25,000 for drug errors related to heparin overdose
New report offers clues on patient satisfaction with hospitals
A Press Ganey Associates report reveals which patients are most and least satisfied with their hospitals.
New deal struck to expand distribution of imaging agent
Cardinal Health and GE Healthcare are partnering to expand the distribution of the imaging agent Myoview.
AHRQ pushes pill cards to improve adherence
The Agency for Healthcare Research & Quality issues instructions for creating pill cards to improve patient adherence.
Pharmacies bemoan generics' shrinking margins
Generics and pharmacy's bottom line.
Whitehouse drug control strategy focuses on illegal Internet sales
The National Association of Boards of Pharmacy applauds President Bush for focusing on illegal Internet sales of prescription drugs
Safeway providing vaccination against shingles
Safeway offers immunization to help prevent shingles
Arizona Senate passes legislation for smoking cessation treatments for Medicaid patients
Arizona Senate approves smoking cessation treatments for state Medicaid beneficiaries
FDA sends early warning of Spiriva's potential stroke risk
Tiotropium bromide is associated with possible increased risk of stroke
Congress to CMS: Small businesses may be harmed by DME bidding program
Congress informs CMS that Medicare durable medical equipment bidding program may harm small businesses
CVS to pay almost $37 million to settle switching of ranitidine
CVS reaches $36.7 million settlement agreement on retail dispensing practices for ranitidine.
Glycerin monograph revised to improve impurity testing
USP glycerin monograph updated
CMS creates diagnosis code for extravasation therapy
Anthracycline extravasation gains new ICD-9-CM code
DigiFab production increased to combat temporary antibody shortage
Fougera and Protherics announce increased DigiFab production to counteract shortage.
Department of Veterans Affairs to deploy mobile pharmacies in times of emergencies
VA putting pharmacies on the road during emergencies
DEA exempts six anabolic steroid products from its regulatory control
The Drug Enforcement Administration is moving three anabolic steroid products out of Schedule III status.
Feds seeking comments to hydroxyurea draft brief
Hydroxyurea's potential to affect reproduction is detailed in a new draft from the National Institute of Environmental Health Sciences, which is now open for comments.
